Metraipolis › archive › dc_484fdcfba13c

Comparative Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Versus Glucagon-Like Peptide-1 (GLP-1) Agonists on Cardiovascular and Renal… — Europe PMC PMID:41523725

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41523725
DOI: 10.7759/cureus.100927
License (as archived): solo-consultazione
Archived: 2026-11-07T00:58:42.199Z
SHA-256 of the archived text: 22d519e2914bb2514104656a4f11333feea1519a6171d8fa399f879cc42b3121
Stable URL of this page: https://metraipolis.com/documento/dc_484fdcfba13c

How to cite

Comparative Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Versus Glucagon-Like Peptide-1 (GLP-1) Agonists on Cardiovascular and Renal… — Europe PMC PMID:41523725 — Europe PMC (en), https://europepmc.org/article/MED/41523725 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_484fdcfba13c (Metraipolis archive dc_484fdcfba13c, sha256 22d519e2914bb2514104656a4f11333feea1519a6171d8fa399f879cc42b3121)

BibTeX

@misc{dc484fdcfba13c,
  title = {Comparative Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Versus Glucagon-Like Peptide-1 (GLP-1) Agonists on Cardiovascular and Renal… — Europe PMC PMID:41523725},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41523725},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_484fdcfba13c; sha256 22d519e2914bb2514104656a4f11333feea1519a6171d8fa399f879cc42b3121},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41523725. Agents can read the archived copy with the MCP tool read_document.